Hemangioendothelioma

subtype

Identifier: CI-CAN-00002844
Entity page: /cancer/hemangioendothelioma ↗
Edges: 36

Neighbours: 14 drugs10 trials
Drawn: 24 of 24 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Hemangioendothelioma investigated for …INVESTIGATED_FOR1 of 1
← investigated for	Sirolimussmall_molecule	unknown	2	Hemangioendothelioma	1	Curated	chembl	graph →
Hemangioendothelioma investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14
investigated in trials for

Hemangioendothelioma studied in …STUDIED_INderived10 of 21show all (up to 200)
→ studied in	NCT03331250Phase 2 · completed Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Epithelioid Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Epithelioid Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07684287Phase 2 · not yet recruiting A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Epithelioid Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07656909Phase 2/Phase 3 · recruiting Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Kaposiform Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07104331Phase 2 · recruiting SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Epithelioid Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06408441recruiting The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Epithelioid Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07477548Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04008238NA · completed Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03967834NA · recruiting Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Epithelioid Hemangioendothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02625389Phase 4 · completed A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active)	—	—	Hemangioendothelioma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains